Loknete Shri Dadapatil Pharate college of Pharmacy Mandavgan Pharata, Maharashtra, India.
Menorrhagia is a medical condition characterized by abnormally heavy or prolonged menstrual bleeding. It can lead to significant discomfort, inconvenience, and even anemia in some cases. Managing menorrhagia typically involves identifying and addressing underlying causes such as hormonal imbalances, uterine fibroids, or bleeding disorders. Treatment options may range from medication and hormonal therapies to surgical interventions like endometrial ablation or hysterectomy. Effective management of menorrhagia is crucial for improving quality of life and preventing complications associated with excessive menstrual bleeding. The topic offers comprehensive investigation into the etiology, symptoms, and treatment modalities concerning excessive menstrual bleeding. This project endeavors to elucidate the physiological intricacies contributing to menorrhagia while presenting a thorough examination of conventional and contemporary therapeutic approaches. By synthesizing current medical literature and clinical expertise, it aims to equip both individuals and healthcare practitioners with the necessary insights to effectively navigate and address this prevalent aspect of women's health. Objective: The objective of a topic on menorrhagia is to educate people, particularly women, about the condition, its symptoms, causes, and management options. By increasing awareness and understanding, the aim is to empower individuals to recognize abnormal bleeding patterns, seek appropriate medical care, and improve overall menstrual health and well-being. Purpose: The purpose of this study is to enhance understanding and facilitate effective management of menorrhagia, a condition characterized by excessive menstrual bleeding. By exploring its causes, symptoms, and treatment options, this research aims to empower individuals and healthcare professionals with the knowledge necessary to improve outcomes and quality of life for those affected by menorrhagia. Results: The results of the menorrhagia disease survey highlight the prevalence and impact of abnormal menstrual bleeding among women. Key findings include a significant number of participants reporting symptoms such as heavy bleeding, prolonged periods, and associated complications like fatigue and anemia. The survey underscores the importance of raising awareness about menorrhagia, promoting early detection, and providing access to effective. Conculsion: Understanding menorrhagia and its management options can empower individuals to address abnormal bleeding patterns effectively. Seeking timely medical care and adopting appropriate treatments can significantly improve menstrual health and overall well-being.
Menorrhagia limits normal activities, and causes anaemia in two thirds of women with objective menorrhagia (loss of 80 mL blood per cycle). Prostaglandin disorders may be associated with idiopathic menorrhagia, and with heavy bleeding due to fibroids, adenomyosis, or use of intrauterine devices (IUDs). Fibroids have been found in 10% of women with menorrhagia overall, and in 40% of women with severe menorrhagia; but half of women having a hysterectomy for menorrhagia are found to have a normal uterus. Menorrhagia is heavy but regular menstrual bleeding. A normal menstrual cycle is 21–35 days in duration with bleeding lasting an average of 7 days. There are few definite causes and fewer definitive tests that reveal a conclusive, treatable cause. While menorrhagia can signals, an endocrinologic disorder, or a gynecologic disease, most causes are idiopathic. Once known physiologic and anatomical causes are eliminated, the problem is generally diagnosed as dysfunctional uterine bleeding (DUB), and treatment is initiated.
What is Menorrhagia?
Menorrhagia is defined as heavy but regular menstrual bleeding. Idiopathic ovulatory menorrhagia is regular heavy bleeding in the absence of recognizable pelvic pathology or a general bleeding disorder. Objective menorrhagia is taken to be a total menstrual blood loss of 80 mL or more in each menstruation. Subjectively, menorrhagia may be defined as a complaint of regular excessive menstrual blood loss occurring over several consecutive cycles in a woman of reproductive age.
Fig 1-A condition of Menorrhagia
Causes of Menorrhagia – Uterine-related problems
Growths or tumors of the uterus that are not cancer; these can be called uterine fibroids or polyps. Cancer of the uterus or cervix. Certain types of birth control—for example, an intrauterine device (IUD).Problems related to pregnancy, such as a miscarriage or ectopic pregnancy, can cause abnormal bleeding. A miscarriage is when an unborn baby (also called a fetus) dies in the uterus. An ectopic pregnancy is when a baby starts to grow outside the womb (uterus), which is not safe.
Hormone-related problems.
Bleeding-related disorders, such as von Willebrand disease (VWD) or platelet function disorder.
Nonbleeding-related disorders
Nonbleeding-related disorders such as liver, kidney, or thyroid disease; pelvic inflammatory disease; and cancer. In addition, certain drugs, such as aspirin, can cause increased bleeding. Doctors have not been able to find the cause in half of all women who have this problem. If you have bleeding such as this, and your gynecologist has not found any problems during your routine visit, you should be tested for a bleeding disorder
Signs of Menorrhagia –
Methodology
The survey utilized a combinationn of quantitative and qualitative methods, including online questionnaires and interviews. Participants were recruited from diverse demographic backgrounds to ensure comprehensive insights into the experiences of individuals with menorrhagia.
Interview questions to physician
Q1. What is Menorrhagia.
Q2. How frequent patients visit you with this problem? Q3. Which age group is mostly having such symptoms?
Q4. Which things lead to the condition? OR What are the causes for menorrhagia. Q5. What are the investigations do in menorrhagia?
Q6. What treatment is recommended to the patients? Q7. Is PCOD/PCOS similar to menorrhagia?
Q8. What preventive measures can be taken
Q9. Is this disease a lifestyle based or hereditary
Q10. What changes can be taken for such prevention of disease?
Interview Answers of physicians
Q1. What is menorrhagia.
Ans - Menorrhagia is a condition in which a cyclic bleeding at normal levels in which the bleeding is excessive or in amount that is greater than 80 ml or duration is extended The disease is based on completely on the uterus in which the only two hormones responsible that is progesterone and estrogen which are responsible for the lining of the endometrium
Q2. How frequent patients visit you with this problem?
Ans - Frequently as of lack of exercises Prevalence in India is 1/4 of the women which ranges from 6% to 40%
Q3. Which age group is mostly having such symptoms?
Ans – On the current reports 80% of the female candidates with has the age below the 20 years symptoms mostly and female more than the age of 30 are facing his conditions that is 20%
Q4. Which things lead to the condition? OR What are the causes for menorrhagia. Ans - According to f i g o international federation of gynecology and obstetrics
PALM stands for: PolypsAdenomyosisLeiomyoma (fibroids)Malignancy These are potential causes of abnormal uterine bleeding or other uterine abnormalities.
COEI stands for:
COEIN - N - that includes entities not yet classified
Q5. What are the investigations do in menorrhagia? Ans - Complete haemogram (CBC)
Bleeding time, clotting time Ultrasonography for married n unmarried Diagnostic endometrial currettage Diagnostic hysteroscopy laproscopy
Q6. What treatment is recommended to the patients?
Ans – 1. General measures to improve the health status of the patient i.e proper diet, and adequate rest during menses, oral administration of haematinics, vitamin B&C, protein supplements
Mirena ICUD
Q7. Is PCOD/PCOS similar to menorrhagia? Ans - PCOS/PCOD is not like menorrhagia
As PCOS/PCOD deals with the disease of ovary whereas menorrhagia deals with uterus and endometrial lining
Q8. What preventive measures can be taken
Ans - Preventive measures for menorrhagia, or heavy menstrual bleeding, can vary depending on the underlying cause. Here are some general preventive measures that may help:
Q9. Is this disease a lifestyle based or hereditary Ans - Both lifestyle as well as hereditary
Q10. What changes can be taken for such prevention of disease? Ans –
Fig 2- Interviewing Dr. Archana S Chikte B.A.M.S M.S. (Stree rog & Prasuti tantra) Private practitioner
Fig 3- Interviewing Dr. Sandhya M Yennewar B.A.M.S D.G. O PhD (scholar) Associate professor (CSMSS ayurvedic College)
Interview questions to Female candidates
Q1. Have you heard about Menorrhagia before?
Q2. How many times have you faced this condition?
Q3. What is the average duration of your menstrual bleeding?
Q4. Do you track your bleeding Regularly?
Q5. What medications or treatment do you take?
Q6. How does this condition affect your daily life?
Q7. What are the reasons you think for such condition?
Q8. How many medications does your doctor prescribes at once?
Q9. How has this condition affected your health?
Q10. Do you take medications on regular basis?
Q11. Do you know any of your friend ongoing this condition?
Q12. Are you having any ongoing medications or syrup?
Table 1-Outcomes Of The Survey Based Study
CONCLUSION
The survey findings highlight the pervasive and multifaceted impact of menorrhagia on individuals' lives, underscoring the pressing need for comprehensive support and management strategies. It is evident that menorrhagia not only affects hysical health but also imposes significant emotional and social burdens on those experiencing it.One of the key takeaways from the survey is the prevalence of menorrhagia across various age groups, indicating that it is not solely a concern for older or younger women but affects individuals across the reproductive age spectrum. This nderscores the importance of addressing menorrhagia as a significant public health issue that requires attention and resources.The impact of menorrhagia on daily activities, work, and social life cannot be overstated. A substantial percentage of respondents reported missing work or school due to heavy menstrual bleeding, highlighting the economic implications of the condition. Moreover, emotional distress and anxiety related to menorrhagia were common among participants, indicating the need for psychosocial support alongside medical interventions.
REFERENCE
Ravankole Pratiksha Rajkumar, Dr. Hemant V. Kamble, Menorrhagia-Understanding and Managing Menstrual Bleeding, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 7, 1177-1183. https://doi.org/10.5281/zenodo.12749166